Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Henan Taloph Raises $63.4 Million to Fund Projects

publication date: Apr 5, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Henan Taloph Pharma will raise 400 million RMB ($63.4 million) by issuing 84 million shares at 4.75 RMB each in a private placement. The company will use the new cash for various capex projects, including production facilities, an R&D center, a growing facility for TCM ingredients and an expansion of its marketing effort. The company said the new facilities will result in an improved mix of products. More details....

Stock Symbol: (SHA: 600222)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners